Find out more about Stacey Rudd's experience
Stacey Rudd's highlights
FEATURED Journal article
ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with 89Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol.
Read moreStacey Rudd's selected work
Illumination of Immune Checkpoint Therapy of Cancer: Molecular Imaging of Immunity with Co..
Research Grant
P1.10-02 ImmunoPET: A Phase 0/1 Study Characterising PD-L1 with 89Zr-Durvalumab (MEDI4736)..
Journal article
MA09.05 Increased PD-L1 Tracer Uptake in Recently-irradiated Lesions in NSCLC: Preliminary..
Journal article
P2.03-01 Initial Biodistribution Data of ImmunoPET A Phase 0/1 Study Characterising PD-L1 ..
Journal article
Imaging immunity in patients with cancer using positron emission tomography
Journal article
Fully Automated Radiosynthesis of [Zr-89]Zr-DFOSq-Durvalumab for Clinical PET Imaging of P..
Conference Proceedings
Stacey Rudd's selected work
Projects
Displaying the 1 most recent project from 1 for Stacey Rudd.
Project Types
1
Research Grant
Scholarly Works
Displaying the 10 most recent scholarly works from 20 for Stacey Rudd.
Credentials
Positions
Postdoctoral Fellow – Inorganic Chemistry
Chemistry
Education
Master of Science (Chemistry)
University of Melbourne
Bachelor of Science
University of Melbourne
Ph.D (Science)
University of Melbourne